Breast Cancer and Metabolic Syndrome Linked Through the Plasminogen Activator Inhibitor-1 Cycle

BioEssays - United States
doi 10.1002/bies.20640
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Role of Plasminogen Activator Inhibitor-1 in the Metabolic Syndrome and Its Regulation

Journal of Food Research
2014English

Increased Concentration of Plasminogen Activator Inhibitor-1 and Fibrinogen in Individuals With Metabolic Syndrome

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2009English

Plasminogen Activator Inhibitor-1 and the Circadian Clock in Metabolic Disorders

Japanese Journal of Thrombosis and Hemostasis
2008English

Metastasis of Transgenic Breast Cancer in Plasminogen Activator Inhibitor-1 Gene-Deficient Mice

Oncogene
Cancer ResearchGeneticsMolecular Biology
2003English

Retraction: The Effects of Residual Platelets in Plasma on Plasminogen Activator Inhibitor-1 and Plasminogen Activator Inhibitor-1-Related Assays

PLoS ONE
Multidisciplinary
2018English

Protumorigenic Activity of Plasminogen Activator Inhibitor-1 Through an Antiapoptotic Function

Journal of the National Cancer Institute
Cancer ResearchOncology
2012English

Does Plasminogen Activator Inhibitor-1 Drive Lymphangiogenesis?

PLoS ONE
Multidisciplinary
2010English

Plasminogen Activator Inhibitor-1 Promotes the Recruitment and Polarization of Macrophages in Cancer

Cell Reports
BiochemistryGeneticsMolecular Biology
2018English

Plasminogen Activator Inhibitor 1 (PAI1) Promotes Actin Cytoskeleton Reorganization and Glycolytic Metabolism in Triple Negative Breast Cancer

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy